Trial
NCT06254911
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI); Genentech, Inc.
Condition
Oropharynx Cancer, Stage I
Intervention
Atezolizumab
Why stopped
Institutional Review
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-27